[go: up one dir, main page]

NO20090054L - Antitumoral dihydropyran-2-on sammensetninger - Google Patents

Antitumoral dihydropyran-2-on sammensetninger

Info

Publication number
NO20090054L
NO20090054L NO20090054A NO20090054A NO20090054L NO 20090054 L NO20090054 L NO 20090054L NO 20090054 A NO20090054 A NO 20090054A NO 20090054 A NO20090054 A NO 20090054A NO 20090054 L NO20090054 L NO 20090054L
Authority
NO
Norway
Prior art keywords
compositions
antitumoral
dihydropyran
antitumoral dihydropyran
Prior art date
Application number
NO20090054A
Other languages
English (en)
Other versions
NO341508B1 (no
Inventor
José Fernando Reyes Benítez
Maria Del Carmen Cuevas Marchante
Ma Jesús Martin López
Andrés Francesch Solloso
Rogelio Fernándes Rodríguez
Laura Coello Molinero
Alberto Rodríguez Vicente
María Garranzo García-Ibarrola
Carmen Murcia Pérez
Francisco Sánchez Sancho
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20090054L publication Critical patent/NO20090054L/no
Publication of NO341508B1 publication Critical patent/NO341508B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20090054A 2006-06-16 2009-01-06 Antitumoral dihydropyran-2-on sammensetninger NO341508B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06380173 2006-06-16
PCT/EP2007/055959 WO2007144423A1 (en) 2006-06-16 2007-06-15 Antitumoral dihydropyran-2-one compounds

Publications (2)

Publication Number Publication Date
NO20090054L true NO20090054L (no) 2009-01-06
NO341508B1 NO341508B1 (no) 2017-11-27

Family

ID=38508885

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20090054A NO341508B1 (no) 2006-06-16 2009-01-06 Antitumoral dihydropyran-2-on sammensetninger
NO20111248A NO20111248L (no) 2006-06-16 2011-09-14 Antitumoral dihydropyran-2-on sammensetninger

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20111248A NO20111248L (no) 2006-06-16 2011-09-14 Antitumoral dihydropyran-2-on sammensetninger

Country Status (29)

Country Link
US (2) US8324406B2 (no)
EP (3) EP2032551B9 (no)
JP (2) JP5117491B2 (no)
KR (1) KR101474031B1 (no)
CN (2) CN101679340B (no)
AR (1) AR061506A1 (no)
AT (1) ATE522514T1 (no)
AU (1) AU2007259257B8 (no)
BR (2) BRPI0713031B8 (no)
CA (1) CA2654334C (no)
CY (1) CY1112103T1 (no)
DK (1) DK2032551T3 (no)
ES (1) ES2371942T3 (no)
HR (1) HRP20110845T1 (no)
IL (1) IL195676A (no)
MX (1) MX2008015754A (no)
MY (1) MY145788A (no)
NO (2) NO341508B1 (no)
NZ (1) NZ573706A (no)
PL (1) PL2032551T3 (no)
PT (1) PT2032551E (no)
RS (1) RS52034B (no)
RU (2) RU2444519C2 (no)
SG (1) SG174830A1 (no)
SI (1) SI2032551T1 (no)
TW (2) TW201213316A (no)
UA (1) UA97369C2 (no)
WO (1) WO2007144423A1 (no)
ZA (1) ZA200810315B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102190643B (zh) * 2007-12-20 2015-02-25 法马马有限公司 抗肿瘤化合物
JP5349500B2 (ja) 2008-02-20 2013-11-20 アクテリオン ファーマシューティカルズ リミテッド アザトリシクリック抗菌性化合物
ES2398939T3 (es) 2008-02-22 2013-03-22 Actelion Pharmaceuticals Ltd. Derivados de oxazolidinona
AR073774A1 (es) 2008-10-07 2010-12-01 Actelion Pharmaceuticals Ltd Compuestos antibioticos oxazolidinona triciclicos
US8507478B2 (en) 2008-10-10 2013-08-13 Actelion Pharmaceuticals Ltd. Oxazolidinyl antibiotics
WO2010149688A2 (en) 2009-06-24 2010-12-29 Pharma Mar, S.A. Antitumoral compounds
GB201309807D0 (en) * 2013-05-31 2013-07-17 Pharma Mar Sau Antibody drug conjugates
CN108467378A (zh) * 2017-02-23 2018-08-31 复旦大学 一种二氢吡喃酮类化合物及其制备方法和用途
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN110790737B (zh) * 2019-11-07 2022-07-22 河南中烟工业有限责任公司 一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法
CA3235048A1 (en) 2021-10-22 2023-04-27 Maria Cristina Mateo Urbano Antitumoral compounds
CN117510448A (zh) * 2023-11-13 2024-02-06 贵州中医药大学 一种二氢吡喃酮衍生物及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117894A1 (en) * 2004-06-03 2005-12-15 Kosan Biosciences Incorporated Leptomycin compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
PT1142887E (pt) * 1993-11-19 2004-08-31 Parke Davis & Co Derivados de 5,6-di-hidropirona como inibidores de protease e agentes antivirais

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117894A1 (en) * 2004-06-03 2005-12-15 Kosan Biosciences Incorporated Leptomycin compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUHNT M ET AL, "Microbial Conversion Products of Leptomycin B", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, (199802), vol. 714, no. 2, ISSN 0099-2240, pages 714 - 720, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
EP2032551B9 (en) 2012-02-29
US20090186938A1 (en) 2009-07-23
TWI373469B (en) 2012-10-01
PT2032551E (pt) 2011-12-06
TW201213316A (en) 2012-04-01
US20120190870A1 (en) 2012-07-26
AU2007259257A8 (en) 2012-04-05
CA2654334C (en) 2014-06-10
ES2371942T3 (es) 2012-01-11
EP2404912A2 (en) 2012-01-11
EP2404913A2 (en) 2012-01-11
EP2032551B1 (en) 2011-08-31
BRPI0713031B8 (pt) 2021-05-25
BRPI0713031B1 (pt) 2020-10-06
TW200811128A (en) 2008-03-01
RU2011133128A (ru) 2013-02-10
CN102336730A (zh) 2012-02-01
HRP20110845T1 (hr) 2011-12-31
IL195676A0 (en) 2009-09-01
AU2007259257B2 (en) 2011-12-08
SI2032551T1 (sl) 2012-01-31
CN101679340A (zh) 2010-03-24
AU2007259257A1 (en) 2007-12-21
BRPI0722429A2 (pt) 2013-11-26
MX2008015754A (es) 2009-01-12
ATE522514T1 (de) 2011-09-15
KR101474031B1 (ko) 2014-12-17
AR061506A1 (es) 2008-09-03
BRPI0713031A2 (pt) 2013-03-12
AU2007259257B8 (en) 2012-04-05
RS52034B (sr) 2012-04-30
CA2654334A1 (en) 2007-12-21
NO20111248L (no) 2008-12-16
RU2009101150A (ru) 2010-07-27
EP2032551A1 (en) 2009-03-11
IL195676A (en) 2012-06-28
NZ573706A (en) 2011-09-30
MY145788A (en) 2012-04-30
CY1112103T1 (el) 2015-11-04
EP2404912A3 (en) 2012-07-25
US8501968B2 (en) 2013-08-06
PL2032551T3 (pl) 2012-01-31
EP2404913A3 (en) 2012-06-06
JP2009539943A (ja) 2009-11-19
US20100048690A2 (en) 2010-02-25
CN101679340B (zh) 2013-06-05
US8324406B2 (en) 2012-12-04
KR20090024261A (ko) 2009-03-06
UA97369C2 (ru) 2012-02-10
DK2032551T3 (da) 2012-01-02
WO2007144423A1 (en) 2007-12-21
JP2012021023A (ja) 2012-02-02
NO341508B1 (no) 2017-11-27
RU2444519C2 (ru) 2012-03-10
HK1130052A1 (en) 2009-12-18
JP5117491B2 (ja) 2013-01-16
SG174830A1 (en) 2011-10-28
ZA200810315B (en) 2010-02-24

Similar Documents

Publication Publication Date Title
BRPI0716325A2 (pt) Composição antimicrobianas
BRPI0810634A2 (pt) Composições fungicidas
BRPI0813775A2 (pt) Composição
EP2280916A4 (en) HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
DE602008005353D1 (de) Lichtstreuende Zusammensetzungen
DK2024406T3 (da) Siliconacrylat-hybridpræparat
DK2634232T3 (da) Sammensætninger
ATE503011T1 (de) Waschmittelzusammensetzungen
ATE502998T1 (de) Waschmittelzusammensetzungen
EP2043136A4 (en) FILMING COMPOSITION
NO20090054L (no) Antitumoral dihydropyran-2-on sammensetninger
ATE498675T1 (de) Waschmittelzusammensetzungen
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
RU2493831C3 (ru) Фармацевтические композиции
FR2899479B1 (fr) Composition cicatrisante
BRPI0810557A2 (pt) composição
BRPI0716458A2 (pt) Composição de vulcanizado
BRPI0811274A2 (pt) Composição
BRPI0812592A2 (pt) Composição assada
DK1929865T3 (da) Cyclopropensammensætninger
BRPI0816995A2 (pt) Composições de ciclosporina
EP2197828A4 (en) FULLEREN-MULTIADDUKT COMPOSITION
BRPI0718141A2 (pt) Composições de frangrâncias
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0820198A2 (pt) composições farmacêuticas